The Open Atherosclerosis & Thrombosis Journal

2011, 4 : 16-18
Published online 2011 December 30. DOI: 10.2174/1876506801104010016
Publisher ID: TOATHERTJ-4-16

Superior Mesenteric Vein Thrombosis Following Treatment of Refractory Immune Thrombocytopenic Purpura with Romiplostim

Dhaval Shah , John Nelson , Gurpreet Lamba , Sivamurthy Kyathari and Karen Seiter
Division of Hematology/Oncology, New York Medical College, Valhalla, New York 10595, USA

ABSTRACT

Romiplostim is a thrombopoietin receptor agonist approved for the treatment of thrombocytopenia in patients with chronic idiopathic thrombocytopenic purpura (ITP) who had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Although thrombotic and embolic complications have been reported in patients receiving romiplostim, these have generally involved coronary artery or cerebral vascular events. Currently we report a patient with severe ITP treated with romiplostim who developed mesenteric venous thrombosis after a hemicolectomy to resect colon cancer.

Keywords:

ITP, Superior mesenteric vein thrombosis, romiplostim.